Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	57	33	27	33	69	44
Market Cap Growth	71.26%	24.62%	-17.94%	-52.77%	55.54%	-43.35%
Enterprise Value	52	37	27	31	59	37
Last Close Price	3.79	2.37	1.79	2.25	4.67	2.95
PS Ratio	1.35	0.88	0.68	0.78	1.92	1.18
PB Ratio	2.17	1.48	0.91	0.91	1.62	0.95
P/TBV Ratio	5.56	8.39	4.39	6.84	3.83	2.46
P/FCF Ratio	8.42	-	4.59	3.90	11.04	8.40
P/OCF Ratio	8.29	-	4.38	3.85	10.86	8.18
PEG Ratio	-	1.52	1.52	1.52	1.52	1.52
EV/Sales Ratio	1.25	0.98	0.67	0.73	1.65	0.99
EV/EBITDA Ratio	38.69	-	-	-	-	-
EV/FCF Ratio	7.68	-	4.56	3.67	9.49	6.99
Debt / Equity Ratio	0.40	0.91	0.63	0.58	0.38	0.36
Debt / EBITDA Ratio	3.17	50.39	32.10	15.97	-	-
Debt / FCF Ratio	1.52	-	3.17	2.51	2.57	3.24
Asset Turnover	0.58	0.48	0.45	0.47	0.40	0.37
Inventory Turnover	1.72	1.53	0.84	1.00	0.92	0.89
Quick Ratio	1.05	0.94	1.00	1.15	1.76	1.45
Current Ratio	1.23	1.15	1.28	1.61	2.37	1.95
Return on Equity (ROE)	-13.28%	-24.88%	-19.41%	-14.38%	-12.51%	-13.53%
Return on Assets (ROA)	-2.86%	-5.11%	-4.44%	-4.02%	-5.30%	-3.97%
Return on Invested Capital (ROIC)	-15.26%	-23.60%	-18.67%	-16.59%	-21.68%	-15.27%
Return on Capital Employed (ROCE)	-7.80%	-14.60%	-11.50%	-8.90%	-11.80%	-9.00%
Earnings Yield	-5.87%	-19.47%	-23.51%	-17.12%	-5.09%	-7.54%
FCF Yield	11.88%	-2.04%	21.77%	25.66%	9.05%	11.91%
Buyback Yield / Dilution	-4.26%	1.67%	1.82%	2.29%	1.70%	1.52%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q